Showing results (151-160 of 521) with videos related to
Sort By:
Pageof 53
Bioinformatics (Oxford, England)|March 3, 2020
Feature set optimization in biomarker discovery from genome-scale dataV Fortino, G Scala, D GrecoClinical and Experimental Immunology|August 1, 1981
Formalin-treated bacteria as selective B cell mitogens: results in primary and acquired immunodeficienciesM C Sirianni, L P Pucillo, M Fiorilli, et al.Rivista Di Neurologia|May 1, 1987
Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosisA Cafaro, M Spadaro, F Pandolfi, et al.Clinical Immunology and Immunopathology|October 1, 1984
Bone marrow transplantation and thymopoietin pentapeptide treatment in two infants with immunodeficiency with predominant T-cell defectsL Businco, P Rossi, R Paganelli, et al.Tumori|August 31, 1987
Case report of a Burkitt-like lymphoma in a bisexual HIV-positive manA E Parrinello, F A Legnami, M Fiorilli, et al.Current Opinion in Pediatrics|June 19, 2015
An update on complex regional pain syndromes in children and adolescentsAmber N Borucki, Christine D GrecoThe Australasian Journal of Dermatology|May 20, 1999
Cardiofaciocutaneous (CFC) syndromeC Schepis, D Greco, C RomanoJournal of Clinical Immunology|January 1, 1986
Phenotypically immature IgG-bearing B cells in patients with hypogammaglobulinemiaM Fiorilli, M Crescenzi, M Carbonari, et al.Thymus|January 1, 1982
Enhancement by TP-1, a thymic extract, of pokeweed mitogen-induced differentiation of B cells from normal subjects but not of those from patients with systemic lupus erythematosusM Fiorilli, M C Sirianni, F Pandolfi, et al.Immunobiology|July 1, 1986
Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-IIIL Fontana, M C Sirianni, G de Sanctis, et al.Pageof 53